1837-55-4, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In a patent, 1837-55-4, molecular formula is C4H2Cl2N2, introducing its new discovery.
TRIAZOLYL PDE10 INHIBITORS
The present invention is directed to substituted triazolyl compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington’s disease, and those associated with striatal hypofunction or basal ganglia dysfunction
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.1837-55-4, you can also check out more blogs about1837-55-4
Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N1162 – PubChem